Friedman Mark Louis 4
4 · Axogen, Inc. · Filed Dec 22, 2021
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Friedman Mark Louis
Vice President of RA/QA
Transactions
- Tax Payment
Common Stock
2021-12-20$9.24/sh−95$878→ 16,588 total - Exercise/Conversion
Common Stock
2021-12-20+375→ 16,683 total - Exercise/Conversion
Restricted Stock Units
2021-12-20−375Exercise: $0.00From: 2021-12-20Exp: 2021-12-20→ Common Stock (375 underlying)
Footnotes (4)
- [F1]This reflects the number of restricted stock units that became vested as of December 18, 2021.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.